Roger E. Susi - Jun 27, 2023 Form 4 Insider Report for IRADIMED CORP (IRMD)

Role: CEO, PRESIDENT, CHAIRMAN, Director, 10%+ Owner
Signature: /s/ Roger E. Susi
Stock symbol: IRMD
Transactions as of: Jun 27, 2023
Transactions value $: -$478,659
Form type: 4
Date filed: 6/28/2023, 05:05 PM
Previous filing: Jun 21, 2023
Next filing: Jul 7, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IRMD	Common Stock	Sale	-$151K	-3.08K	-0.71%	$49.09	430K	Jun 27, 2023	By Roger E. Susi Revocable Trust	F1, F2
transaction	IRMD	Common Stock	Sale	-$327K	-6.92K	-1.61%	$47.32	423K	Jun 28, 2023	By Roger E. Susi Revocable Trust	F1, F3
holding	IRMD	Common Stock						2.36M	Jun 27, 2023	By Matthew Susi 2008 Dynasty Trust	F4
holding	IRMD	Common Stock						2.36M	Jun 27, 2023	By Phillip Susi 2008 Dynasty Trust	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 13, 2023.
F2	This transaction was executed in multiple trades at prices ranging from $48.50 to $49.34. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3	This transaction was executed in multiple trades at prices ranging from $47.10 to $48.57. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4	The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose.